“We found that adding in a specific antibiotic to the medical treatment also resulted in fewer recurring infections, fewer infections in other places on the body and fewer people passing on the infection to other members of the household,” David Talan, MD, lead study author and professor in the department of emergency medicine and department of medicine, division of infectious diseases at the University of California Los Angeles. “This translates into fewer medical visits and reduced healthcare costs.”
The researchers examined more than 1,200 patients who underwent treatments for abscesses across five emergency departments and found that 93 percent of those given an inexpensive, generic antibiotic for seven days post-surgery didn’t experience infection, compared to 86 percent of those in the placebo group.
More articles on infection control:
Copper surfaces can take down MRSA, according to UK study
Antiseptic baths in ICUs shown not to increase drug-resistance in MRSA
Should hospitals decolonize MRSA carriers?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
